INTRODUCTION

The Himalaya Drug Company, a Bangalore based Indian multinational pharmaceutical company
was established in 1930 by Mohammed Manal. He had a clear vision of bringing Ayurveda to
society in a modern manner and unravelling the enigma behind the 5,000-year-old medical
system. To generate novel medications and cures, ancient ayurveda writings were consulted,
indigenous plants were chosen, and formulations were subjected to modern pharmacological,
toxicological, and safety examinations. Today the company has offices in India, the United
States, the Middle East, Asia, Europe, and Oceania, and its products are offered in 106 countries
worldwide. The company employs around 290 researchers who use ayurvedic herbs and
minerals.

Himalaya Herbal Healthcare offers "pharmaceuticals, personal care, baby care, well-being,
nutrition, and animal health products," among other things. One of their most well-known and
popular items is the Neem Face Wash. Its flagship product, Liv.52, is a liver medication that was
initially released in 1955. Mothercare products were launched in 2016 after considerable study
and development in India's ancient Ayurvedic medical systems. As of 2015, the company sold its
products in 91 countries, with approximately half of its income coming from outside India.

HISTORY
Mr. M. Manal watched a villager soothe a restless elephant by giving it the root of the herb
Rauwolfia serpentina while riding through the forests of Burma. Fascinated by the herb's effect
on the elephant, he returned to India in search of scientific evidence as to why this specific plant
would have such a good, soothing effect. Himalaya was born when young Manal's mother gave
him her bangles to sell so he may pursue his career. Mohammed Manal founded the company in
1930 in Dehradun with the goal of modernising Ayurveda via scientific study. Despite his lack of
any scientific training, he had a passion for nature, an insatiable curiosity, and a solid confidence
in herbal medicine. But he was also determined that if herbal therapy was to be taken seriously, it
needed to be supported by empirical evidence. People still believed in herbal goodness in the
1930s, but the expanding influence of Western education meant that critical reasoning was
becoming more essential, and conventional ideologies and belief systems were being questioned.

Mr. Manal began his work after thoroughly comprehending the science underlying this unique
plant. He purchased a hand-operated tablet-compressing machine. His shoulders would ache at
night from the exertion of creating a few hundred tablets, one little tablet at a time. But his
efforts were rewarded. Serpina, the world's first anti-hypertensive medication, was developed
from this extraordinary plant in 1934.
Himalaya moved to Bombay in the 1950s. All the action taking place there. When Meraj Manal,
son of Mohammed Manal informed his father that he was considering transferring the company
to Bangalore, it obviously did not go over well. In reality, he self-financed this move by selling
his Mumbai apartment in order to create a manufacturing facility there. Himalaya was able to
develop high-quality items because of the infrastructure provided by the Bangalore plant. It was
one of the first herbal production plants in India to receive a certificate for good manufacturing
practises (GMP). Most importantly, the facility allowed Himalaya to flex its muscles overseas.
The company's major break came in 1955, when it launched Liv.52, a hepatoprotective that
quickly became its flagship brand. Even today, Liv.52 is the pharmaceutical portfolio's crown
jewel, generating over Rs 250 crore in sales and being the only herbal treatment in India's top ten
selling pharmaceuticals.

The year 1975 was a watershed moment for Himalaya, both good and bad. It relocated to
Bangalore and took the decision to expand into the US, the world's largest and most competitive
market. Meraj Manal relocated to the United States to research the business, giving special
attention to quality and safety regulations. He pushed the R&D team to create goods that
complied with US regulatory requirements. This increased overall compliance and helped
Himalaya India make a stronger case for its medications with doctors in the United States. The
Himalayan psyche was even more thoroughly ensconced in the mantra of quality, safety, and
efficacy, which eventually gave the corporation its competitive edge.

The Dietary Supplement Health and Education Act (DSHEA) was passed by the US FDA in
1994, allowing herbal items that met the new standards and regulations to be sold as dietary
supplements in the US. Himalaya had a line of medicinal items dubbed the 'Care' line ready to
go. In early 1996, two years after DSHEA came into force, Himalaya launched its range of
dietary supplements in America. The United States was followed by Russia, West Asia, APAC,
and Europe. Himalaya's therapeutic line is registered as herbal pharmaceuticals or medicines in
numerous markets.

Himalaya scientists began developing personal care products, which were first released in 1999
under the Ayurvedic Concepts brand, which later became Himalaya Herbals. Personal care
currently accounts for 38 percent of India's revenue. Himalaya is one of the top players in the
face cleaning and lip care segments, with a fast-growing presence in hair care as well, despite
being a relatively new entrant in the personal care industry. It has a market share of over 20% in
the face wash area, making it the country's largest brand.

Founded in 1930, the Himalaya legacy now spans over 90 years, stretching from one man, to his
son, to his grandson. Himalaya Herbal Healthcare has transformed a long-honored herbal
tradition into a comprehensive line of modern, unique formulae and single herbs dedicated to
making the world a better place one person at a time.